March 23, 2020 / 5:48 AM / 10 days ago

BRIEF-Bayer, India’s Curadev Sign Research Collaboration And License Agreement

March 23 (Reuters) - Bayer AG:

* BAYER AND CURADEV SIGN RESEARCH COLLABORATION AND LICENSE AGREEMENT TO DEVELOP NOVEL STING ANTAGONISTS ACROSS INDICATIONS

* COLLABORATION AIMS TO DISCOVER NEW DRUG CANDIDATES FOR TREATMENT OF LUNG DISEASES, CARDIOVASCULAR DISEASES AND OTHER INFLAMMATORY DISEASES

* UNDER TERMS OF AGREEMENT, CURADEV WILL RECEIVE AN UPFRONT PAYMENT

* CURADEV WILL RECEIVE RESEARCH FUNDING DURING RESEARCH TERM AND MIGHT BE ELIGIBLE FOR PRE-CLINICAL, CLINICAL AND SALES MILESTONES OF POTENTIALLY OVER EUR 250 MILLION AS WELL AS ROYALTIES OF SINGLE DIGIT PERCENTAGES OF NET SALES Source text for Eikon: (Berlin Speed Desk)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below